Clinical trial Recruiting at 1 site Interventional Ages 18 and up

NMT EasyFit Sensor and Cable usability and data collection

Official title: Evaluate Functionality and Use of the NMT EasyFit Sensor and NMT EasyFit Cable

Run by GE Healthcare · NCT07394140 · Data updated 2026-11-12

This study tests how well clinicians can use the NMT EasyFit Sensor with the NMT Cable to monitor neuromuscular block in adults during procedures requiring paralytic medications.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorGE Healthcare
Industry-sponsored
Locations1 site (Loma Linda, California)
StatusRecruiting
StartedJune 18, 2026
Main results expectedOctober 31, 2026
Study endsDecember 31, 2026
Registry record updatedJuly 8, 2026
Trial IDNCT07394140 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years and older undergoing a clinically indicated procedure that requires paralytic medication and planned NMT monitoring with the NMT ElectroSensor.

Probably not a fit

Patients unlikely to benefit include those not receiving paralytic medication or not using the NMT ElectroSensor for monitoring.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study collects feedback from clinical users on the functionality and use of the NMT Sensor and NMT Cable, including the collection of raw parameter data from the device. The NMT Sensor non-invasively delivers electrical stimuli to the ulnar nerve and records EMG responses from the adductor pollicis to quantify neuromuscular block. The sensor is designed for single-use and connects to a reusable cable for use with GE HealthCare NMT systems. Participants are adults undergoing procedures that require paralytic medication, with monitoring conducted using the NMT ElectroSensor on the hand/forearm. The study evaluates device usability, data capture quality, and potential workflow implications in a real-world clinical setting.

Why it matters

Potential benefit: If successful, the findings could improve ease of use and reliability of neuromuscular monitoring during procedures requiring paralysis.

How similar studies have gone: Previous work with similar neuromuscular monitoring devices has shown promise in usability and data accuracy, but this exact sensor/cable setup is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Study subject (male or female) is age 18 years or older (≥18 years).
2. Study subject must have the ability to understand and provide written informed consent.
3. Study subject is undergoing a clinically indicated procedure requiring the use of paralytic medication.
4. Study subject will have the primary NMT monitoring conducted using an NMT ElectroSensor on the hand/forearm.

Exclusion Criteria:

1. Are known to be pregnant.
2. Are breastfeeding.
3. Suffering from an infection(s) that requires isolation.
4. Deformity, scar tissue, tattoos, or other characteristics at the sensor application area that could interfere (e.g., nerve damage) with the completion of the study procedure or identify a study subject.
5. Subjects requiring rapid sequence induction
6. Subjects expected to be at risk from participation for any reason, such as those with known allergy or sensitivity to adhesive materials that may be used in the study.
7. Direct employees or contractors of GE HealthCare, or any company that makes NMT monitoring devices (sensors, cables, modules).
8. NMT ElectroSensor placed on the foot/ankle

Where it's running

  • Loma Linda University Health
    Loma Linda, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.